Synthetic “Alien” DNA Provides Opportunities for Disease Diagnostics and Treatment
To help understand how DNA may have evolved on other planets, UF researcher Dr. Steven Benner and his partners synthesized DNA-like molecular systems with more than four nucleotides in the laboratory.
Atsena Therapeutics Receives Rare Pediatric Disease Designation From the U.S. FDA for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation (RPD) for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Camera in Space to Capture the Impossible
Satlantis has been developing a camera to photograph the universe's dark matter -- which, by the way, is invisible.
First Type 1 Diabetes Patient Enrolled in Rise Therapeutics’ Latest Clinical Trial
Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, announced it has enrolled its first patient in its R-5280 placebo-controlled, blinded, Phase 1b type 1 diabetes clinical trial.
JPMorgan Upgrades Solid Biosciences Stock, Sees Growth Potential
JPMorgan upgraded Solid Biosciences stock, a biotechnology company that acquired UF startup AavantiBio, from Neutral to Overweight, and increased the price target to $15.00 from the previous $10.00. The firm's decision reflects a positive outlook on the company's prospects, particularly with upcoming developments expected in the fourth quarter.
RTI Surgical Has a New Chief Commercial Officer
UF startup RTI Surgical has appointed Chad Croasdale as chief commercial officer for his more than 20 years of commercial and financial experience in the medtech industry.
NIH Awards $2.8 Million to UF Researchers To Develop At-Home HIV Test Kit
A new, easy-to-use HIV-detection test kit being developed at the University of Florida using advanced CRISPR technology shows promise as an early-warning alarm system that could save millions of lives.
Axogen, Inc. Announces Full Launch of Avive+ Soft Tissue Matrix™
UF startup Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced the launch of its newest product, Avive+ Soft Tissue Matrix™.
Satlantis Is Part of the Consortium Selected by ESA for the Spanish Component of the Atlantic Constellation
The consortium led by Elecnor Deimos has successfully secured one of the two parallel contracts awarded by the European Space Agency (ESA) for the definition of the Spanish Component of the Atlantic Constellation. The core team of the consortium, comprised solely of Spanish entities, includes Alen Space, Satlantis, and DHV Technology.
Underwater Data Centers Are the Future. But a Speaker System Could Cripple Them.
A new study from a group of cybersecurity and robotics researchers at the University of Florida and the University of Electro-Communications in Japan reveals for the first time a critical vulnerability of underwater data centers: sound. Carried by dense water, and targeting the resonant frequencies of hard drives, sound injection attacks can make servers unresponsive and crash networks. After just a few minutes, some hard drives are even permanently destroyed. However, the scientists also developed a machine learning algorithm that can accurately identify sound attacks, allowing the system to respond before it crashes.
